DENVER, Jan. 28, 2026 (GLOBE NEWSWIRE) -- CRISPR gene-editing, and related genome engineering technologies, are reshaping industries from medicine to materials, with breakthroughs in treating genetic ...
The power of artificial intelligence (AI) and advanced computing has made it possible to design genetic sequences encoding ...
Last year, a ten-month-old baby in the US was the first person in the world to have their rare genetic disease effectively ...
Thermo Fisher Scientific Inc. TMO is slated to release fourth-quarter 2025 results on Jan. 29, before market open. In the last reported quarter, earnings of $5.79 per share beat the Zacks Consensus ...
DeepMind’s AlphaGenome AI model could help solve the problem of predicting how variations in noncoding DNA shape gene ...
AlphaGenome is a leap forward in the ability to study the human blueprint. But the fine workings of our DNA are still largely ...
The tool helps scientists understand how single-letter mutations and distant DNA regions influence gene activity, shaping ...
Researchers from the Faculty of Engineering at The University of Hong Kong (HKU) have developed two innovative deep-learning ...
Innovative programmer Steve Klabnik, known for his contributions to Rust, unveils Rue, a new systems programming language ...
Savara Inc. (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced the amendment of its loan and security agreement with Hercules Capital, Inc.
Enzymes with specific functions are becoming increasingly important in industry, medicine and environmental protection. For ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results